Back to Trades
Kiely John
DirectorCIK 0001781149
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025
Across 1 filing between 2025, Kiely John, Director, has disclosed $295.4K in transactions — all concentrated in Amneal Pharmaceuticals, Inc. (AMRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $295.4K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.